Key result
A National Research Council committee recommended developing an antipoliovirus drug for potential posteradication outbreaks, though some members doubted its feasibility.
A National Research Council committee recommends developing antipoliovirus drugs for potential post-eradication outbreaks, though feasibility is debated.
Answers are grounded in this paper and cite their sources.
May inform post-eradication polio preparedness; leaves open feasibility of antipoliovirus drug development.
As efforts to wipe out polio intensify in the handful of countries where the disease still occurs naturally, public health experts are thinking about what comes next. In a report released last week, a seven-person committee appointed by the National Research Council in Washington, D.C., argued for developing an antipoliovirus drug in the event of a posteradication outbreak. But whereas everyone on the panel endorsed that advice in principle, not all felt it was achievable.
No takes yet. Share an insight, caveat, or question.
Jennifer Couzin (2006) studied Polio. Antipoliovirus drug was evaluated. A National Research Council committee recommended developing an antipoliovirus drug for potential posteradication outbreaks, though some members doubted its feasibility.
Synapse has enriched 10 related papers. Consider them for comparative context: